Biosimilars Report features expert review of new developments in biosimilars including regulation and developments in the US and clinician and payer perspectives of first biosimilars approved in the US.

The current issue features expert perspective on biosimilars from Dr. Sanjiv S. Agarwala.
 
 

Continue


The second issue highlights the clincian and payer perspectives on the first biosimilar approved in the US, by Dr. Gary H. Lyman and Dr. Edward Pezalla.
 
 

Continue


The premier issue highlights the fundamentals of biosimilar regulation and development in the US and recently released materials on biosimilars, Dr. Edward Li.
 
 

Continue

Access other Therapeutic Areas:


 

New & Noteworthy